Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pieter Van Vlierberghe"'
Autor:
G. Grant Welstead, Rab K. Prinjha, Pieter Van Vlierberghe, Thomas Trimarchi, Aifantis Iannis, Sofia Bakogianni, Adolfo A. Ferrando, Panagiotis Ntziachristos, Luyao Xu, Charles G. Mullighan, Rudolf Jaenisch
Publikováno v:
Clinical Cancer Research. 21:PR03-PR03
The cure rate for childhood acute lymphoblastic leukemia (ALL) has dramatically improved, yet up to 25% of patients experience disease recurrence. T cell ALL (T-ALL) represents 15% of pediatric and 25% of adult ALL and it is classified as a high-risk
Autor:
Sofia Bakogianni, Pieter Van Vlierberghe, Thomas Trimarchi, Charles G. Mullighan, Rudolf Jaenisch, Panagiotis Ntziachristos, Rab K. Prinjha, G. Grant Welstead, Luyao Xu, Adolfo A. Ferrando, Aifantis Iannis
Publikováno v:
Clinical Cancer Research. 21:B24-B24
This abstract is being presented as a short talk. A full abstract is printed in the Proffered Abstracts section (PR03) of the Conference Proceedings. Citation Format: Panagiotis Ntziachristos, Grant Welstead, Thomas Trimarchi, Sofia Bakogianni, Luyao
Autor:
Pieter Van Vlierberghe, Inge Van de Walle, Wouter Van Loocke, Franki Speleman, Charles E. de Bock, Pieter Rondou, Jan Cools, Kaat Durinck, Jean Soulier, Bruce Poppe, Joni Van der Meulen, Tom Taghon
Publikováno v:
Clinical Cancer Research. 21:B05-B05
Introduction: Combined activation of specific oncogenes is a general feature of human cancer and suggests that co-occurrence of particular oncogenic factors provides a selective advantage during cellular transformation. However, the exact molecular m